In the 1-week titration phase , participants received desvenlafaxine 100 mg/d ( no titration ) , desvenlafaxine 50 mg/d , desvenlafaxine 25 mg/d ( 4 days ) then 50 mg/d ( 3 days ) , or desvenlafaxine 25 mg/d .
